Jerusalem, Arnold G.

HRN: 24-70-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
CLOXACILLIN 500MG (CAP)
03/25/2024
04/01/2024
ORAL
500mg
Q6hours
Skin And Soft Tissue Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: